BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 14, 2012
View Archived Issues
Promising data presented from phase II Cinryze combination trial
Read More
GeoVax obtains FDA approval to advance adjuvanted HIV vaccine to clinic
Read More
Studies address suitability of allopregnanolone to treat Niemann-Pick disease type C
Read More
GM-CSF-adjuvanted vaccine provides long-term protection in HIV model
Read More
Hadasit Bio-Holdings to receive further funding from Israeli government
Read More
FDA approves first cell-based product made from allogeneic human cells and bovine collagen
Read More
Immunogenicity and favorable tolerability reported for H5N1 flu vaccine
Read More
New data reported on biOasis immunoconjugate for HER2+ breast cancer
Read More
Epistem and GlaxoSmithKline enter biomarker collaboration
Read More
Enrollment begins in phase I RX-3117 trial
Read More
Calcium channel blocker for hypertension clear to enter clinical testing in China
Read More
PX'Therapeutics begins phase I trial of HIV vaccine
Read More
Calzada subsidiary discloses encouraging in vitro data on AOD-9603
Read More
Hybrigenics clear to conduct phase II inecalcitol study in CLL
Read More
Hutchison MediPharma reports new JAK inhibitors
Read More
Merck KGaA announces new inhibitors of FADK 1
Read More
Isotechnika and FDA reach SPA agreement on voclosporin trial
Read More
Novel caspase inhibitors discovered at Banyan Biomarkers
Read More
Phase I study of CBLB-502 advances
Read More
Novel apoptosis inducers prepared by U.S. university scientists
Read More
New Trevena G protein-biased mu opioid receptor ligand has analgesic activity
Read More
New RSV vaccines developed at GenVec
Read More
Phase III OMS-302 study meets endpoints
Read More
FDA accepts CRTX-080 NDA for filing
Read More
Attogen patents novel FGFR2IIIc-specific antibodies
Read More
Abbott identifies new potential analgesics
Read More